Smallpox
📧 Sign up to get email alerts when something new happens for Smallpox.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Safety and Efficacy of CJ-50300 in Healthy Volunteers [Phase 2, Phase 3]
This report summarizes the results of a Phase 2/3 trial evaluating CJ-50300 for safety and efficacy in healthy volunteers in the context of …
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the CJ Smallpox Vaccine in previously vaccinated healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)
A long-term study of healthy adults vaccinated with a single dose of the Smallpox vaccine (Lister strain) has completed; sponsor is Sanofi.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Dressing Preparations for Smallpox [Phase 1, Phase 2]
This document reports the completion of Phase 1/Phase 2 clinical trials evaluating dressing preparations for smallpox.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults [Phase 2]
Phase 2 trial evaluating the safety and tolerability of a smallpox vaccine in healthy young adults has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax® [Phase 1]
Phase 1 trial comparing a cell-cultured smallpox vaccine to Dryvax, evaluating safety, reactogenicity, immunogenicity, and pock lesion forma…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination [Phase 2]
Phase 2 trial assessing dose, safety, and tolerability of a new smallpox vaccine in adults without prior vaccination; results posted.
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults [Phase 2]
Phase 2 dose study of ACAM2000 smallpox vaccine in adults previously vaccinated, with completed results.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the Dryvax live vaccinia vaccine for protection against smallpox…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Dryvax Dilution-Prev Vacc Adults [Phase 2]
Phase 2 trial evaluating diluted Dryvax smallpox vaccine in adults has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Human Immune Responses Smallpox [Phase 1]
Phase 1 clinical trial evaluating human immune responses to smallpox has been completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT [Phase 1, Phase 2]
This update reports the PILOT trial evaluating APSV, a vaccinia virus vaccine, in vaccinia-naive subjects across Phase 1 and Phase 2. The st…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: APSV in Vaccinia Naive Adults [Phase 2]
Phase 2 trial of APSV in vaccinia-naive adults for smallpox has completed, according to a ClinicalTrials.gov update.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Phase I Trial of an Investigational Small Pox Medication [Phase 1]
Phase I study of SIGA Technologies' investigational smallpox antiviral tecovirimat (ST-246) has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: ACAM 3000 MVA at Harvard Medical School [Phase 1, Phase 2]
A completed Phase 1/2 trial of the ACAM 3000 MVA smallpox vaccine sponsored by NIAID was conducted at Harvard Medical School, with results p…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox [Phase 1]
A Phase I/II trial of a Modified Vaccinia Virus Ankara (MVA) vaccine against smallpox in healthy participants has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Trial of Smallpox Vaccine [Phase 1]
The document reports the completion of a Phase I trial of a smallpox vaccine conducted in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Safety and Immunogenicity of CJ-50300 [Phase 1]
A Phase 1 study evaluating the safety and immune response of CJ-50300 for smallpox has completed.
-
CLINICAL_TRIALS research · 2007-01-15Clinical Trial Update: Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 safety and immunogenicity study of LC16m8, a modified smallpox vaccine, in healthy volunteer…